Comparison of Use of Neoadjuvant Systemic Treatment for Breast Cancer and Short-term Outcomes Before vs During the COVID-19 Era in Ontario, Canada

IMPORTANCE: In response to an increase in COVID-19 infection rates in Ontario, several systemic treatment (ST) regimens delivered in the adjuvant setting for breast cancer were temporarily permitted for neoadjuvant-intent to defer nonurgent breast cancer surgical procedures. OBJECTIVE: To examine th...

Descripción completa

Detalles Bibliográficos
Autores principales: Habbous, Steven, Tai, Xiaochen, Beca, Jaclyn M, Arias, Jessica, Raphael, Michael J., Parmar, Ambica, Crespo, Andrea, Cheung, Matthew C, Eisen, Andrea, Eskander, Antoine, Singh, Simron, Trudeau, Maureen, Gavura, Scott, Dai, Wei Fang, Irish, Jonathan, Krzyzanowska, Monika, Lapointe-Shaw, Lauren, Naipaul, Rohini, Peacock, Stuart, Yeung, Lyndee, Forbes, Leta, Chan, Kelvin K. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346546/
https://www.ncbi.nlm.nih.gov/pubmed/35917122
http://dx.doi.org/10.1001/jamanetworkopen.2022.25118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346546/
https://www.ncbi.nlm.nih.gov/pubmed/35917122
http://dx.doi.org/10.1001/jamanetworkopen.2022.25118

Ejemplares similares